SWOG clinical trial number
SWOG-9143
A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma
Closed
Phase
Accrual
100%
Published
Abbreviated Title
A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma
Activated
08/15/1992
Closed
09/15/1994